Facebook posts help facilitate belief that HPV vaccine is dangerous to health
Monique Luisi identified a negative trend on Facebook related to how people perceive the HPV vaccine.
Transcript
Consiglio: The most commonly sexually transmitted infection in the U.S. is the human papillomavirus, or HPV. While the CDC has years of data showing the HPV vaccine is safe and effective, HPV vaccination rates still remain low, and negative, misleading social media posts about the vaccine may be one reason why.
In a recent study, MU assistant professor Monique Luisi studied more than 6,500 HPV vaccine-related posts on Facebook from 2006 to 2016. She found nearly 40% of the Facebook posts amplified a perceived risk about the safety of the HPV vaccine, which may cause some people to develop a false perception about the vaccine’s safety.
Luisi: “Negative posts really have the capacity to capture people’s attention, and by sharing and resharing these posts, they have a wider audience which can increase the skepticism that people have in HPV vaccines or vaccines in general.”
Consiglio: With the rollout of COVID-19 vaccines now underway, similar skepticism may be amplified by false or misleading social media posts, even as public health officials state the benefits of getting vaccinated. Therefore, Luisi reminds us of the importance of verifying what we read on social media before sharing, and understanding the influence we may have on others while online.
Luisi: “It’s important to read carefully, we live in a wonderful age where we have so much access to information, but information doesn’t always mean knowledge, so read, continue to research, and make sure that you ask your doctor or health professional to weigh in on things you have read.”
Consiglio: I’m Brian Consiglio, with a Spotlight on Mizzou.
Related Stories

Spotlight on Mizzou
Asian carp could pulverize world hunger, MU researcher finds
Powdering Asian carp could address an environmental problem and a global malnutrition crisis.

Spotlight on Mizzou
MU Research Reactor to supply radioisotope for targeted cancer therapy
The University of Missouri Research Reactor (MURR®) has entered into an exclusive multi-year agreement with Advanced Accelerator Applications International to provide a key ingredient in a targeted therapy for certain types of cancerous tumors.

Spotlight on Mizzou
$4 million grant will help teach computer coding skills to rural Missouri students
University of Missouri program earns grant to help advance STEM education in underserved Missouri school districts.

Spotlight on Mizzou
Killing cancer by unleashing the body’s own immune system
University of Missouri scientist demonstrates a new bacteria-based strategy for turning the body’s own immune system against cancer.
Subscribe to
Show Me Mizzou
Stay up-to-date on all things Mizzou when you subscribe to the Show Me Mizzou newsletter. Issues will arrive in your inbox every Tuesday, Wednesday and Thursday.